COVID 19 histopathology

Overview of COVID-19

  • COVID-19 is a significant public health crisis, first identified in December 2019.

  • The disease is caused by the SARS-CoV-2 virus, leading to over 481 million infections and more than 6 million deaths globally by the end of the study.

  • Affects all age groups, with older individuals and those with pre-existing conditions facing higher risks.

Characteristics of the Disease

  • Clinical presentation ranges from asymptomatic to multiorgan failure and death.

  • Common symptoms include:

    • Fever

    • Cough

    • Fatigue

    • Possible nasal discharge, headaches, diarrhea, and gastrointestinal issues.

Virology and Pathogenesis

  • Coronaviruses belong to the Coronavirinae subfamily and can impact both humans and animals.

  • Viral Particle:

    • Size: 80 to 220 nm, with a positive-strand RNA genome.

    • Genome structure: 5’-RdRp-S-E-M-N-3’, involved in encoding structural proteins (N, E, M, S) and replication proteins (RhRp).

  • Entry Mechanism:

    • The virus enters host cells by binding its spike (S) protein to the ACE2 receptor, influencing viral pathogenesis.

Histopathological Findings

  • Common findings include:

    • Diffuse alveolar damage, vascular congestion, edema.

    • Pulmonary hemorrhage, cardiomegaly, and ventricular dilation observed in fatal cases.

  • Histology indicates shared patterns with other respiratory viral illnesses, but COVID-19 displays unique vascular issues such as thrombosis and microthrombosis.

Damage to Organs

Lung

  • Predominantly affected, with findings of:

    • Edema, desquamation of pneumocytes.

    • Hyaline membranes and signs of acute respiratory distress syndrome.

Other Organs

  • Liver

    • Alterations include cirrhosis, microvesicular steatosis, and lobular inflammation.

  • Kidney

    • Chronic kidney disease and acute duct lesions.

  • Heart

    • Myocardial fibrosis and inflammatory infiltrates.

Study Limitations in Colombia

  • Limited necropsy and postmortem tissue sampling during COVID-19 restrictions hinder comprehensive studies.

  • The research is based on 50 fatal cases confirmed through various diagnostic methods, providing insights into the histopathology of COVID-19.

Figures Overview

  1. Lung Histology: Normal alveolar structure and bronchiole sections.

  2. Lung Damage: Different stages of Diffuse Alveolar Damage detailed.

  3. Additional Alterations: Various forms of edema, reactive hyperplasia, and vascular changes.

  4. Spleen & Liver Histology: Comparisons of normal and affected structures in these organs.

  5. Summary of Findings: Frequencies of identified histopathological changes in various organs, evidencing the extensive impact of COVID-19.

Conclusion

  • The histopathological changes provide valuable insight into the disease's progression and complications due to SARS-CoV-2.

  • Ongoing evaluations and further studies are essential for understanding the long-term effects and pathological mechanisms involved.